Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like What You Need to Know About Apostle January 28, 2018 AEterna Zentaris Announces Presentation Regarding Macrilen At 99th Annual Meeting Of March 2, 2017 Zenosense: MIDS Quantitative Testing Results March 12, 2017
